To qualify for Wegovy treatment, adults should have a body mass index (BMI) of at least 30 kg/ m or a BMI of at least 27 kg/m with at least one weight-related condition, such as hypertension (high blood pressure), diabetes, or dyslipidemia (high cholesterol)
Pharmacy paid claims for Zepbound, Wegovy and Mounjaro for Commercial Book of business (excludes restricted clients), July 2024 to April 2025
Research suggests it promotes fat loss while preserving lean mass, which aligns well with Retatrutides metabolic profile
View BPC-157 Table of Contents What Is BPC-157 and What Does It Do
In practice, this may be someone whose acute shedding exposed pre-existing androgenetic alopecia, accelerated the visibility of patterned miniaturization or left a stable density deficit after reversible contributors were corrected